So while NCAA Tournament teams began preparing for their first-round opponents on Sunday night, Texas won't know who it is ...

The biotech is exploring opportunities for a reverse merger or other business combinations. CFO and now interim CEO Anup ...

Incyte (NASDAQ:INCY – Free Report) had its price target reduced by Truist Financial from $74.00 to $72.00 in a report issued on Tuesday,Benzinga reports. They currently have a hold rating on the ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

Confluent (NASDAQ:CFLT – Get Free Report)‘s stock had its “outperform” rating reissued by analysts at William Blair in a ...